{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T08:08:30Z","timestamp":1774598910348,"version":"3.50.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1097\/mbc.0b013e328365776f","type":"journal-article","created":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T15:15:36Z","timestamp":1387379736000},"page":"142-150","source":"Crossref","is-referenced-by-count":10,"title":["Assessment of changes in membrane properties of platelets from patients with chronic myeloid leukaemia in different stages of the disease"],"prefix":"10.1097","volume":"25","author":[{"given":"Viola M.","family":"Popov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Vladareanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horia","family":"Bumbea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihaela-Georgeta","family":"Moisescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minodora","family":"Onisai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Minodora","family":"Iordache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tudor","family":"Savopol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210203","first-page":"277","article-title":"Alterations of platelet biochemical and functional properties in newly diagnosed type 1 diabetes: a role in cardiovascular risk Diabetes Metab Res R","volume":"27","author":"Vignini","year":"201","journal-title":"ev"},{"key":"R2-8-20210203","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1476-511X-9-97","article-title":"Fatty acids, membrane viscosity, serotonin and ischemic heart disease.","volume":"9","author":"Cocchi","year":"2010","journal-title":"Lipids Health Dis"},{"key":"R3-8-20210203","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.brainres.2008.02.005","article-title":"Platelet membrane fluidity and NaK ATPase activity in acute stroke.","volume":"1205","author":"Nanetti","year":"2008","journal-title":"Brain Res"},{"key":"R4-8-20210203","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00002093-200201000-00009","article-title":"Blood platelet membrane fluidity and the exposition of membrane protein receptors in Alzheimer disease (AD) patients: preliminary study.","volume":"16","author":"Kozubski","year":"2002","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"R5-8-20210203","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/09537109876564","article-title":"Membrane lipid fluidity of blood platelets: a common denominator that underlies the opposing actions of various agents that affect platelet activation in whole blood.","volume":"9","author":"Watala","year":"1998","journal-title":"Platelets"},{"key":"R6-8-20210203","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00418-005-0076-y","article-title":"The platelet receptor for type III collagen (TIIICBP) is present in platelet membrane lipid microdomains (rafts).","volume":"125","author":"Maurice","year":"2006","journal-title":"Histochem Cell Biol"},{"key":"R7-8-20210203","first-page":"221","article-title":"Role of reactive oxygen species in platelet function in normal and chronic myeloproliferative disorders.","volume":"45","author":"Vladareanu","year":"2008","journal-title":"Romanian J Biochem"},{"key":"R8-8-20210203","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3324\/haematol.2012.064618","article-title":"Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapy.","volume":"97","author":"Neelakantan","year":"2012","journal-title":"Haematologica"},{"key":"R9-8-20210203","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5045\/kjh.2010.45.1.73","article-title":"A case of subdural hematoma in patient with chronic myeloid leukemia treated with high-dose imatinib mesylate.","volume":"45","author":"Kim","year":"2010","journal-title":"Korean J Hematol"},{"key":"R10-8-20210203","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1752-1947-5-215","article-title":"Improvement of platelet dysfunction in chronic myelogenous leukemia following treatment with imatinib: a case report.","volume":"5","author":"Shimabukuro-Vornhagen","year":"2011","journal-title":"J Med Case Rep"},{"key":"R11-8-20210203","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/leu.2008.78","article-title":"BCRABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress.","volume":"22","author":"Koptyra","year":"2008","journal-title":"Leukemia"},{"key":"R12-8-20210203","doi-asserted-by":"crossref","first-page":"24273","DOI":"10.1074\/jbc.M002094200","article-title":"The BCRABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells.","volume":"275","author":"Sattler","year":"2000","journal-title":"J Biol Chem"},{"key":"R13-8-20210203","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/leu.2008.253","article-title":"Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation.","volume":"22","author":"Landolfi","year":"2008","journal-title":"Leukemia"},{"key":"R14-8-20210203","first-page":"109","article-title":"Membrane fluidity of blood cells.","volume":"27","author":"Hollan","year":"1996","journal-title":"Haematologia (Budap)"},{"key":"R15-8-20210203","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bcmd.2005.12.028","article-title":"Platelet regulation by NOcGMP signaling and NAD(P)H oxidase-generated ROS.","volume":"36","author":"Begonja","year":"2006","journal-title":"Blood Cells Mol Dis"},{"key":"R16-8-20210203","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0271-5317(99)00137-2","article-title":"Genistein inhibits reactive oxygen species (ROS) production, shape change, and aggregation in rat platelets.","volume":"20","author":"Schoene","year":"2000","journal-title":"Nutr Res"},{"key":"R17-8-20210203","doi-asserted-by":"crossref","first-page":"15774","DOI":"10.1073\/pnas.1007909107","article-title":"1215-lipoxygenase-derived lipid peroxides control receptor tyrosine kinase signaling through oxidation of protein tyrosine phosphatases.","volume":"107","author":"Conrad","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-8-20210203","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/sj.leu.2403370","article-title":"Constitutively activated phosphatidylinositol 3-kinase primes platelets from patients with chronic myelogenous leukemia for thrombopoietin-induced aggregation.","volume":"28","author":"Kubota","year":"2004","journal-title":"Leukemia"},{"key":"R19-8-20210203","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1600-0609.1988.tb00835.x","article-title":"Platelet function in myeloproliferative disorders: characterization and sequential studies show multiple platelet abnormalities, and change with time.","volume":"40","author":"Baker","year":"1988","journal-title":"Eur J Haematol"},{"key":"R20-8-20210203","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2141.1989.tb07755.x","article-title":"Platelet membrane abnormalities in myeloproliferative disorders: decrease in glycoproteins Ib and IIbIIIa complex is associated with deficient receptor function.","volume":"73","author":"Mazzucato","year":"1989","journal-title":"Br J Haematol"},{"key":"R21-8-20210203","first-page":"873","article-title":"Platelet abnormalities in myeloproliferative disorders.","volume":"10","author":"Holme","year":"1990","journal-title":"Clin Lab Med"},{"key":"R22-8-20210203","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02887996","article-title":"Redistribution of platelet membrane glycoprotein IV and release of intracellular alpha-granule thrombospondin in patients with chronic myelogenous leukemia.","volume":"17","author":"Liu","year":"1997","journal-title":"J Tongji Med Univ"},{"key":"R23-8-20210203","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood-2011-09-381400","article-title":"In vivo imaging visualizes discoid platelet aggregations without endothelium disruption and implicates contribution of inflammatory cytokine and integrin signaling.","volume":"119","author":"Nishimura","year":"2012","journal-title":"Blood"},{"key":"R24-8-20210203","first-page":"757","article-title":"Integrins and coagulation: a role for ROSredox signaling Antioxid Redox S","volume":"6","author":"Gregg","year":"2004","journal-title":"ignal"},{"key":"R25-8-20210203","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1161\/01.ATV.0000145574.90840.7d","article-title":"Players in the platelet game, reactive oxygen species.","volume":"24","author":"Krotz","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R26-8-20210203","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and quality control studies of real-time quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia: a Europe Against Cancer program.","volume":"17","author":"Gabert","year":"2003","journal-title":"Leukemia"},{"key":"R27-8-20210203","first-page":"7","article-title":"Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission.","volume":"10","author":"Serpa","year":"2010","journal-title":"BMC Blood Disord"},{"key":"R29-8-20210203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MBC.0b013e3283177b03","article-title":"Resolution of platelet function defects with imatinib therapy in a patient with chronic myeloid leukaemia in chronic phase.","volume":"20","author":"Ng Ashley","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R30-8-20210203","first-page":"Su2","article-title":"Alteration of platelet function in patients with chronic myeloid leukemia.","volume":"7","author":"Popov","year":"2009","journal-title":"J Thromb Haemostasis"},{"key":"R31-8-20210203","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0090-6980(00)00082-4","article-title":"Oxidative response and membrane modification of diabetic platelets challenged with PAF.","volume":"62","author":"Tiano","year":"2000","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"R32-8-20210203","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00001721-200404000-00006","article-title":"Assessment of platelet activation in myeloproliferative disorders with complementary techniques.","volume":"15","author":"Bermejo","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R33-8-20210203","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/ajh.2830220408","article-title":"Acquired von Willebrand disease and storage pool disease in chronic myelocytic leukemia.","volume":"22","author":"Mohri","year":"1986","journal-title":"Am J Hematol"},{"key":"R34-8-20210203","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/09537100500235958","article-title":"Defective platelet beta-N-acetyl hexosaminidase content and release in chronic myeloproliferative disorders.","volume":"17","author":"Emiliani","year":"2006","journal-title":"Platelets"},{"key":"R35-8-20210203","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0049-3848(02)00354-7","article-title":"Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes.","volume":"108","author":"Villmow","year":"2002","journal-title":"Thromb Res"},{"key":"R36-8-20210203","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1182\/blood.V116.21.5125.5125","article-title":"Membrane fluiditys role in platelet function in patients with myeloproliferative neoplasms.","volume":"116","author":"Popov","year":"2010","journal-title":"Blood Online"},{"key":"R37-8-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.03.036","article-title":"Genomic instability in myeloid malignancies: Increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair.","volume":"270","author":"Sallmyr","year":"2008","journal-title":"Cancer Lett"},{"key":"R38-8-20210203","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1182\/blood-2008-09-180604","article-title":"Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemia.","volume":"114","author":"Quintas-Cardama","year":"2009","journal-title":"Blood"},{"key":"R39-8-20210203","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1182\/blood.V88.11.4304.4304","article-title":"Crkl is constitutively tyrosine phosphorylated in platelets from chronic myelogenous leukemia patients and inducibly phosphorylated in normal platelets stimulated by thrombopoietin.","volume":"88","author":"Oda","year":"1996","journal-title":"Blood"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0b013e328365776f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:32:07Z","timestamp":1620959527000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201403000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e328365776f","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}